Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ewing

Showing results (171-180 of 230) with videos related to

Pageof 23
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2009
Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibitionJonathan R St-Germain, Paul Taylor, Jiefei Tong, et al.
The Prostate|April 26, 2006
Germline ATBF1 mutations and prostate cancer riskJunyan Xu, Jurga Sauvageot, Charles M Ewing, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2010
Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in miceMark M Ewing, Margreet R de Vries, Mariette Nordzell, et al.
Genes, Chromosomes & Cancer|June 1, 1997
Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancerD F Jarrard, G S Bova, C M Ewing, et al.
Science Signaling|November 4, 2010
DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitinationZhanwen Du, Jing Song, Yong Wang, et al.
Cancer Biology & Therapy|August 28, 2018
ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1D Liu, Y Skomorovska, J Song, et al.
Cancer Research|December 26, 2001
Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinomaS Zha, W R Gage, J Sauvageot, et al.
Journal of Veterinary Internal Medicine|May 1, 1995
Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disordersF W Bell, J S Klausner, D W Hayden, et al.
Oncotarget|September 30, 2016
Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screeningBinod Kumar, Salar Khaleghzadegan, Brian Mears, et al.
The American Journal of Pathology|October 31, 2006
A novel role of myosin VI in human prostate cancerThomas A Dunn, Shenglin Chen, Dennis A Faith, et al.
Pageof 23

Showing results (171-180 of 230) with videos related to

Sort By:
Pageof 23
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2009
Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibitionJonathan R St-Germain, Paul Taylor, Jiefei Tong, et al.
The Prostate|April 26, 2006
Germline ATBF1 mutations and prostate cancer riskJunyan Xu, Jurga Sauvageot, Charles M Ewing, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2010
Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in miceMark M Ewing, Margreet R de Vries, Mariette Nordzell, et al.
Genes, Chromosomes & Cancer|June 1, 1997
Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancerD F Jarrard, G S Bova, C M Ewing, et al.
Science Signaling|November 4, 2010
DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitinationZhanwen Du, Jing Song, Yong Wang, et al.
Cancer Biology & Therapy|August 28, 2018
ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1D Liu, Y Skomorovska, J Song, et al.
Cancer Research|December 26, 2001
Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinomaS Zha, W R Gage, J Sauvageot, et al.
Journal of Veterinary Internal Medicine|May 1, 1995
Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disordersF W Bell, J S Klausner, D W Hayden, et al.
Oncotarget|September 30, 2016
Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screeningBinod Kumar, Salar Khaleghzadegan, Brian Mears, et al.
The American Journal of Pathology|October 31, 2006
A novel role of myosin VI in human prostate cancerThomas A Dunn, Shenglin Chen, Dennis A Faith, et al.
Pageof 23